Daniel P. Bezerra has a B.Pharm. and Ph.D in pharmacology, and specializes in the pre-clinical development of new antineoplastic drugs. Currently, he is mainly involved in the study of ruthenium complexes; natural products; oxidative stress; PI3K/AKT/mTOR, MAPK, NFkB and p53 signaling; hepatocellular carcinoma; colon carcinoma; acute myeloid leukemia; and cancer/leukemia stem cells.
Research Keywords & Expertise
Leukemia
Natural Products
Ruthenium(II) complex
Colon cancer
Liver Cancer
Fingerprints
17%
Leukemia
7%
Liver Cancer
5%
Natural Products
5%
Colon cancer
5%
Ruthenium(II) complex
Short Biography
Daniel P. Bezerra has a B.Pharm. and Ph.D in pharmacology, and specializes in the pre-clinical development of new antineoplastic drugs. Currently, he is mainly involved in the study of ruthenium complexes; natural products; oxidative stress; PI3K/AKT/mTOR, MAPK, NFkB and p53 signaling; hepatocellular carcinoma; colon carcinoma; acute myeloid leukemia; and cancer/leukemia stem cells.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
